Previous 10 | Next 10 |
Key Regional Health Plan Further Expands Number of Covered Lives to Over 280 Million PARSIPPANY, NJ, April 02, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that Medica, one of the largest health plans spanning numerous states throughout the ...
Interpace Diagnostics Group, Inc. (IDXG) Q4 2018 Earnings Conference Call March 19, 2019 4:30 PM ET Company Participants Jack Stover - President and Chief Executive Officer Jim Early - Chief Financial Officer Conference Call Participants Yi Chen - H.C. Wainwright & Co. ...
Interpace Diagnostics (NASDAQ: IDXG ): Q4 GAAP EPS of -$0.15. More news on: Interpace Diagnostics Group, Inc., Earnings news and commentary, Stocks on the move, Consumer stocks news, , Read more ...
Business Progress and Recent Accomplishments Highlighted and Discussed Further on Conference Call PARSIPPANY, NJ, March 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”) today announced financial res...
PARSIPPANY, NJ, March 04, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) (“Interpace” or “the Company”) announced today that the Pittsburgh Business Times has designated Interpace Diagnostics as its 2018 Top Life Sciences Company award winner...
Interpace to Host Fourth Quarter and Full Year 2018 Results Conference Call/Webcast PARSIPPANY, NJ, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), a fully integrated commercial and bioinform...
PARSIPPANY, NJ, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that BMJ Open Gastroenterology , an on-line, peer-reviewed, open access gastroenterology journal dedicated to publishing high-quality medical research from all discipline...
PARSIPPANY, NJ, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) today announced the Company will attend the 21 st BIO CEO & Investor Conference being held in New York, NY at the New York Marriott Marquis on February 11 th & 12 th , 2019. The Company wi...
PARSIPPANY, N.J., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the closing of its previously announced underwritten public offering of 9,333,334 shares of its common stock at a p...
Interpace Diagnostics (NASDAQ: IDXG ) prices its public offering of 9,333,334 common stock at a public of $0.75/share, for gross proceeds of ~$7M. More news on: Interpace Diagnostics Group, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Interpace Biosciences Inc. Company Name:
IDXG Stock Symbol:
NASDAQ Market:
Interpace Biosciences Inc. Website:
PARSIPPANY, NJ, June 04, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics ® , a subsidiary of Interpace Biosciences ® (OTCQX: IDXG), is proud to announce that new data demonstrating the application of advanced sequencing technologies in pancreatic cancer was published as an e-ab...
PARSIPPANY, NJ, May 09, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the first quarter ended March 31, 2024 and provided a business and financial update. First quarter Net ...
GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...